Showing 61-65 of 146 news & articles:
Data Book podcast: Joe Zabinski of OM1 talks about AI and ChatGPT

Chief Healthcare Executive Apr 17, 2023 Ron Southwick Listen to the full podcast >> Artificial intelligence is being touted as having the potential to revolutionize healthcare. Joe Zabinski says that the future may not be too far away. “In terms of how close we are to this having widespread adoption, I think we’re closer than[…]

OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

April 13, 2023 BusinessWire Read the full release >> The digital phenotyping platform, PhenOM, is delivering personalized and actionable healthcare insights around diagnosis, treatment, risk, utilization, and clinical trials BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated[…]

Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study

Taylor & Francis Online April 6, 2023 Read the full manuscript >> Objective: To investigate the impact of steroid-eluting implants after endoscopic sinus surgery (ESS) on health care resource use (HCRU) in chronic rhinosinusitis patients with (CRSwNP) and without (CRSsNP) nasal polyps. Methods: This retrospective, observational cohort study using real-world evidence data included adult patients[…]

Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >>   A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]